SAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

Authors :: L. Costa
D. Hitzl
N. Lindegger
B. Dampier
Günther G. Steger
Fabio Puglisi
M. Casa-Nova
C. Timcheva
Source :: Annals of Oncology. 29:viii119
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Registry study
medicine
Locally advanced
Hematology
medicine.disease
business
Metastatic breast cancer

Full Text Access

Tools